Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)

National Institutes of Health · United States government procurement

Closed September 05, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

The Population Assessment of Tobacco and Health (PATH) Study provides the scientific community with biospecimens (urine, plasma, serum, and genomic DNA) and related research data on behaviors, attitudes, biomarkers and health outcomes associated with tobacco use in the U.S. This opportunity allows investigators to apply for access to the biospecimens from the PATH Study. Information about the PATH Study and this resource may be found on the PATH Study series page (https://doi.org/10.3886/Series606) at the University of Michigans National Addiction and HIV Data Archive Program (NAHDAP) website, part of the Inter-University Consortium for Political and Social Researchs (ICPSR) website.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyNational Institutes of Health
CountryUnited States
CategoryMonitoring Evaluation
PublishedAugust 24, 2023
Procurement stageActive solicitation
ClosedSeptember 05, 2026
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: U.S. Government (Simpler.Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.

Browse Similar Open Opportunities in United States

Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)

See every United States Monitoring Evaluation opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Monitoring Evaluation intelligence report in your inbox

A personalized report on United States Monitoring Evaluation opportunities, emailed in 5-10 minutes. One per month, no account needed.